Neuro Event Labs launches Nelli project
It receives excellent responses for its interface and videos. Nelli aids clinicians' decision-making as seizure diaries lack accuracy.
See the latest news and media coverage for Neuro Event Labs. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of AI-based seizure detection systems
neuroeventlabs.comLast updated
In short: Neuro Event Labs secured FDA clearance for its Nelli system, raised €2.0M for US expansion, and established clinical partnerships in the UK.
It receives excellent responses for its interface and videos. Nelli aids clinicians' decision-making as seizure diaries lack accuracy.
The hospital becomes Nelli's Centre of Excellence for NIHR-funded at-home AI monitoring of epilepsy patients with intellectual disabilities. This supports NHS transition to community care.
Martijn W. and Reinhard Krickl seek meetings with CROs, pharma/biotech firms, hospitals, and partners. They highlight recent FDA 510(k) clearance for Nelli Seizure Monitoring System.
The 510(k) clearance enables clinical use in US hospitals. Nelli is a non-contact AI-driven tool for detecting seizure events. It expands monitoring capacity and aids trials.
Neuro Event Labs has received FDA clearance for clinical use of its Nelli Seizure Monitoring System in the hospital setting.
Track Neuro Event Labs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.